Brigit Biofarmaka Teknologi Tbk. vs Nippon Indosari Corpindo Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Nippon Indosari Corpindo Tbk. trades at Rp610 (market cap 3.8T, 501K 24h volume). The key difference: Nippon Indosari Corpindo Tbk. is far larger — about 22× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 501K). Which is the better fit depends on your goals.
| OBAT | ROTI | |
|---|---|---|
Market Cap | 172.82B | 3.8T |
Volume | 592.2K | 501K |
Lot | 5.92K | 5.01K |
Turnover | 147.05M | 307.52M |
Average Price | 248.31 | 613.81 |
Value | 147.05M | 307.52M |
Indicative Equilibrium Price | 254 | 610 |
Indicative Equilibrium Volume | 10 | 1.67K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Nippon Indosari Corpindo (the company) was established under its original name of PT Nippon Indosari Corporation base on notarial deed No.11 of Benny Kristianto, S.H, dated on Mar 8, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 71 of Isbandi, S.H., dated Feb 24, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on ROTI →